AbbVie, Inc.
No trades
Bonds
Below is the list of AbbVie, Inc. corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
|---|---|---|---|---|---|---|---|---|---|
| AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 7.00% | 26 K | 76.04% | 4.750% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| 6.65% | 0 | 89.60% | 2.625% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
| AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 6.40% | 12 K | 83.25% | 4.850% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 6.38% | 124 K | 81.98% | 4.625% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
| 5.62% | 4.11 M | 98.06% | 5.500% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.52% | 5.67 M | 98.24% | 5.400% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.51% | 4.08 M | 83.25% | 4.250% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.51% | 1.78 M | 91.76% | 4.875% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.50% | 13.69 M | 101.45% | 5.600% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.49% | 0 | 87.26% | 4.450% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.49% | 26 K | 90.47% | 3.200% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.48% | 0 | 90.73% | 4.700% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.47% | 602 K | 91.47% | 4.750% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.44% | 214 K | 93.18% | 4.850% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.41% | 2.76 M | 99.23% | 5.350% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 5.39% | 1.94 M | 91.52% | 4.625% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 5.27% | 10 K | 94.75% | 4.550% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
| 5.10% | 12.9 M | 89.56% | 4.050% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.80% | 0 | 95.93% | 4.300% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.74% | 0 | 98.15% | 4.500% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.71% | 6.76 M | 98.83% | 4.550% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.69% | 7.53 M | 103.75% | 5.200% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.61% | 2.33 M | 102.97% | 5.050% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.23% | 3.74 M | 103.35% | 4.950% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029 | 4.20% | 0 | 93.42% | 2.125% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
| 4.12% | 0 | 99.63% | 3.200% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.06% | 20.8 M | 96.89% | 3.200% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.03% | 3.65 M | 103.28% | 4.875% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 4.01% | 2.43 M | 102.38% | 4.800% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.91% | 378 K | 101.59% | 4.650% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.89% | 1.17 M | 100.98% | 4.250% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.87% | 664.5 K | 99.15% | 2.950% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.86% | 508 K | 101.16% | 4.800% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.16% | 0 | 126.76% | 4.750% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 128.71% | 4.850% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.13% | 0 | 121.31% | 4.250% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 3.10% | 0 | 90.10% | 1.250% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.79% | 0 | 97.82% | 2.125% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.68% | 0 | 99.86% | 2.625% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.57% | 0 | 123.74% | 4.550% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| 2.56% | 0 | 98.79% | 2.125% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| 2.54% | 0 | 96.65% | 0.750% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
| −5.92% | 0 | 111.17% | 2.950% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| — | — | — | 4.400% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
| — | 0 | 89.50% | 4.400% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |